Adenosine vs Diltiazem for Treatment of SVT in the ED
ConditionSupraventricular Tachycardia (SVT)
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-100
SponsorAnne E. Zepeski
About this trial
This is a small, pilot study with a primary goal of assessing patient perceptions of two medication treatments for supraventricular tachycardia in adult patients treated in the Emergency Department.
Eligibility criteria
Qualifiers
Adult patients (18 years and older)
Diagnosis of acute, stable SVT in the emergency department
Disqualifiers
Receipt of IV AV-nodal blocking agents prior to study enrollment (includes adenosine, non-dihydropyridine calcium channel blockers, beta-antagonists in pre-hospital and/or hospital setting).
Reported or confirmed personal history of Wolff-Parkinson-White (WPW) syndrome
History of heart failure with reduce ejection fraction (HFrEF) (LVEF</= 40%)
Severe bronchoconstrictive lung disease
Trial design
Treatments tested in this trial
- adenosine
- diltiazem
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Anne E. Zepeski
Lead sponsor
University of Iowa
Sponsor institution
Source ClinicalTrials.gov